#	Pagina
attuale pagina	/open-h2020/projects/213257/index.html
-1	/open-h2020/projects/225691/index.html
-2	/open-h2020/projects/217642/index.html
-3	/open-h2020/projects/205480/index.html
-4	/open-h2020/projects/207914/index.html
-5	/open-h2020/projects/207633/index.html
-6	/open-h2020/projects/219745/index.html
-7	/open-h2020/projects/203265/index.html
-8	/open-h2020/projects/221408/index.html
-9	/open-h2020/projects/196406/index.html

Opendata, web and dolomites

ISSD

The Implantable Subcutaneous String Defibrillator, an innovative subcutaneous cardioverterdefibrillator for a new paradigm in cardiac rhythm management.

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

ISSD project word cloud

Explore the words cloud of the ISSD project. It provides you a very rough idea of what is the project "ISSD" about.

procedure defibrillators comfort point rates replacement commercialisation deploy sca icd implantation generators chain deployment seamless first view invisible fits outpatient global dimension helped lives plan snake market cardiac rechargeable prevent designed aesthetical 350 arrest totally wireless avoiding leads demand inserted financial device meet invested robustness instrument countries technologies carry sme barriers threating vascular implanted heart trials transvenous veins clinical death 8m 3m pose issd improves life security europe2 subcutaneous sound claiming scas trade remaining almost patients impacts cardioverter stage rapid halving cyber complications efficiency drawbacks solutions implantable wires solid sudden introduces investment subcutaneously fast icds move overcome causes untouched min

Project "ISSD" data sheet

The following table provides information about the project.

Coordinator	NEWPACE LTD Organization address address: 13 GRANITH ST city: CAESAREA postcode: 3088900 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Israel [IL]
Project website	http://www.newpacemedical.com
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)) 2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
Code Call	H2020-SMEINST-1-2016-2017
Funding Scheme	SME-1
Starting year	2017
Duration (year-month-day)	from 2017-11-01 to 2018-02-28

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	NEWPACE LTD NEWPACE LTD Organization address address: 13 GRANITH ST city: CAESAREA postcode: 3088900 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	IL (CAESAREA)	coordinator	50˙000.00

Map

Project objective

Sudden Cardiac Arrest (SCA) is a life-threating heart condition and one of the most common causes of death in developed countries claiming more than 350,000 lives per year in Europe2. There are currently two different implantable technologies to prevent SCAs: 1) Transvenous Implantable Cardioverter-Defibrillators (T-ICDs), which are implanted with wires that snake through veins into the heart; and 2) Subcutaneous Implantable Cardioverter-Defibrillators (S-ICD), which also have generators and leads but avoiding leads within the heart. However this solutions pose many drawbacks such as major complications to the vascular system, replacement needs, aesthetical and comfort impacts, complex implantation procedures and cyber-security issues.

The ISSD™ introduces a new dimension in subcutaneous ICDs. It is a totally integrated device fully inserted subcutaneously, with no leads within the heart, thus remaining the vascular system untouched. It is a wireless rechargeable device, halving replacement rates when compared to current technologies and it is totally seamless and integrated, so no generators or leads are needed. This makes the device almost invisible and improves patients comfort. It is designed from a cyber-security point of view and can be implanted in a rapid outpatient procedure (20 min on average).

So far, we have invested €8M which have helped us to ensure its robustness and efficiency and move into the commercialisation stage. To further develop the ISSD™, overcome market barriers and deploy it at a European and global level we need a further investment of €3M which will allow us to carry out clinical trials and set up a solid EU value chain able to meet the large demand expected during the first years of commercialisation.

The proposed work in Phase 1 of the SME instrument fits into our overall plan to reach the market by contributing the financial resources needed to plan a fast sound wider deployment of the ISSD™ and its market uptake.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ISSD" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ISSD" are provided by the European Opendata Portal: CORDIS opendata.